We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
-0.39%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$579M
AUM Growth
+$10.3M
Cap. Flow
+$40.5M
Cap. Flow %
7%
Top 10 Hldgs %
80.36%
Holding
86
New
13
Increased
9
Reduced
4
Closed
5
Avg Time Held
2.8 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.7 years

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$23.8M
2
COCH icon
Envoy Medical
COCH
+$4.26M
3
ROC icon
Rank One Computing Corp
ROC
+$3.19M
4
CRIS icon
Curis
CRIS
+$2.48M
5
VENU icon
Venu Holding Corp
VENU
+$2.31M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.13M
2
OWLT icon
Owlet
OWLT
+$1.46M
3
RHLD icon
Resolute Holdings Management
RHLD
+$1.04M
4
GPCR icon
Structure Therapeutics
GPCR
+$696K
5
LWLG icon
Lightwave Logic
LWLG
+$538K

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.59%
2 Industrials 23.83%
3 Healthcare 13.54%
4 Materials 5.99%
5 Technology 5.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
PHYS icon
51
Sprott Physical Gold
PHYS
$14.9B
$444K 0.08%
12,540
– –
2019 Q4
25 quarters
ERNA icon
52
Eterna Therapeutics
ERNA
$2.53M
$398K 0.07%
+80,000
New +$1.28M
2026 Q1
0 quarters
RVMDW icon
53
Revolution Medicines Inc Warrant
RVMDW
$108M
$358K 0.06%
200,000
– –
2023 Q4
9 quarters
CARR icon
54
Carrier Global
CARR
$45.3B
$338K 0.06%
6,000
– –
2020 Q2
23 quarters
MSAI icon
55
MultiSensor AI
MSAI
$9.48M
$283K 0.05%
30,562
– –
2024 Q2
7 quarters
CLRB icon
56
Cellectar Biosciences
CLRB
$11.2M
$254K 0.04%
100,000
– –
2025 Q3
2 quarters
PYPL icon
57
PayPal
PYPL
$48.9B
$240K 0.04%
5,300
– –
2020 Q1
24 quarters
BNY icon
58
Bank of New York Mellon
BNY
$96.4B
$237K 0.04%
2,000
– –
2020 Q1
24 quarters
OTIS icon
59
Otis Worldwide
OTIS
$26.8B
$231K 0.04%
3,000
– –
2020 Q2
23 quarters
TMDX icon
60
Transmedics
TMDX
$2.65B
$209K 0.04%
2,100
– –
2025 Q4
1 quarter
NSRX icon
61
Nasus Pharma
NSRX
$37.1M
$199K 0.03%
+89,848
New +$464K
2026 Q1
0 quarters
XOM icon
62
ExxonMobil
XOM
$718B
$182K 0.03%
1,075
– –
2020 Q2
23 quarters
LION icon
63
Lionsgate Studios
LION
$3.28B
$157K 0.03%
16,413
– –
2025 Q3
2 quarters
CDNS icon
64
Cadence Design Systems
CDNS
$89.3B
$146K 0.03%
525
– –
2020 Q2
23 quarters
AENTW icon
65
Alliance Entertainment Holding Corp Warrants
AENTW
$120K 0.02%
200,000
– –
2023 Q2
11 quarters
SIRI icon
66
SiriusXM
SIRI
$9.15B
$117K 0.02%
5,061
– –
2024 Q3
6 quarters
XAIR icon
67
Beyond Air
XAIR
$2.18M
$59.7K 0.01%
4,324
– –
2024 Q3
6 quarters
ERNAW icon
68
Ernexa Therapeutics Warrants
ERNAW
$344K
$56K 0.01%
+2,000,000
New +$118K
2026 Q1
0 quarters
RVMD icon
69
Revolution Medicines
RVMD
$40.6B
$54.1K 0.01%
556
– –
2023 Q4
9 quarters
ARKF icon
70
ARK Blockchain & Fintech Innovation ETF
ARKF
$912M
$45.6K 0.01%
1,200
– –
2022 Q1
16 quarters
ARKW icon
71
ARK Next Generation Technology ETF
ARKW
$2.25B
$36.2K 0.01%
300
– –
2022 Q1
16 quarters
OPFI.WS icon
72
DELISTED
OppFi Inc Warrants
OPFI.WS
$32.5K 0.01%
250,000
– –
2021 Q3
18 quarters
ARKG icon
73
ARK Genomic Revolution ETF
ARKG
$2.09B
$21.8K ﹤0.01%
825
– –
2022 Q1
16 quarters
QBTS icon
74
D-Wave Quantum Inc
QBTS
$4.86B
$21.6K ﹤0.01%
+1,500
New +$31.7K
2026 Q1
0 quarters
IONQ icon
75
IonQ
IONQ
$13.9B
$21.6K ﹤0.01%
+750
New +$28.8K
2026 Q1
0 quarters
1 2
3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2026 Portfolio in Review

As of Q1 2026, Bleichroeder LP held 86 positions worth $579M, up 1.8% from $568M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Bleichroeder LP deployed $40.5M of net new capital in Q1 2026, opening 13 new positions and adding to 9 existing holdings. Its largest new stake was Envoy Medical: 6,250,000 shares worth $4.16M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, up from 38% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Linde, an estimated $3.13M trimmed.

  • Bleichroeder LP's largest Q1 2026 buy was Envoy Medical: 6,250,000 shares worth $4.16M.
  • Bleichroeder LP added most to State Street SPDR S&P 500 ETF Trust in Q1 2026, an estimated $23.8M increase.
  • Bleichroeder LP's biggest Q1 2026 reduction was Linde, cutting an estimated $3.13M.
  • Bleichroeder LP fully exited Structure Therapeutics in Q1 2026, selling an estimated $696K.
  • Bleichroeder LP's ten largest holdings make up 80% of its $579M portfolio in Q1 2026.
  • Bleichroeder LP opened 13 new positions and closed 5 in Q1 2026.
  • Bleichroeder LP's portfolio value rose 1.8% quarter-over-quarter to $579M.

Based on Bleichroeder LP's 13F filing for Q1 2026, filed 14 May 2026.